You just read:

Mitsubishi Tanabe Pharma Canada Announces Canadian Authorization Of RADICAVA™ (edaravone) To Treat ALS

News provided by

Mitsubishi Tanabe Pharma America, Inc.

Oct 04, 2018, 12:37 ET